Abramson BL, Nelson SM. PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events. Can Cardiol Today [Internet]. 2025 Mar. 19 [cited 2025 Apr. 4];1(1):20–25. Available from: https://canadiancardiologytoday.com/article/view/1-1-Abramson_et_al